NCT05800834 2023-09-28
MorphineGEL
Instituto Nacional de Cancer, Brazil
Phase 2 Unknown
Instituto Nacional de Cancer, Brazil
University of California, Davis
Jiangxi Provincial Cancer Hospital
University of New Mexico
National Taiwan University Hospital